ARCHIVES

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

This article is from The Cancer Letter archive.

Vol. 11 No. 04 | January 25, 1985

Download PDF Visit The Full Archive

Related Articles

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

Stop Suffering And Death “All Around Us”? Von Eschenbach Speeches At FDA Omit 2015 Goal.

February 17, 2006

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011